22 research outputs found

    Study on the Formative Expression on the Popularization of Luxury Goods

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ) --์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :๋™์–‘ํ™”๊ณผ,2007.Maste

    (The) effect of progressive tensional force on mRNA expression of os

    No full text
    ์น˜์˜ํ•™๊ณผ/๋ฐ•์‚ฌ[ํ•œ๊ธ€] ์น˜์•„ ์ด๋™์€ ๊ต์ •๋ ฅ์ด๋ผ๋Š” ๊ธฐ๊ณ„์  ์ž๊ทน์— ๋Œ€ํ•œ ์น˜์ฃผ์ธ๋Œ€์™€ ์น˜์กฐ๊ณจ์˜ ์ƒํ˜ธ ์ƒ๋ฆฌ์  ์ž‘์šฉ์— ์˜ํ•ด ์ผ์–ด๋‚˜๊ฒŒ ๋œ๋‹ค. ์น˜์•„์— ๊ต์ •๋ ฅ์ด ๊ฐ€ํ•ด์ง€๊ฒŒ ๋˜๋ฉด ์น˜์ฃผ์ธ๋Œ€๋Š” ๊ธฐ๊ณ„์  ์ž๊ทน์„ ์ƒํ™”ํ•™์  ์‹ ํ˜ธ์ฒด๊ณ„๋กœ ์ „ํ™˜ํ•˜์—ฌ ์น˜์กฐ๊ณจ์˜ ํก์ˆ˜์™€ ์ƒ์„ฑ์„ ์กฐ์ ˆํ•˜์—ฌ ์น˜์•„์ด๋™์ด ๊ฐ€๋Šฅํ•˜๊ฒŒ ํ•œ๋‹ค. ์ง€๊ธˆ๊นŒ์ง€ ์•Œ๋ ค์ง„ ๋ฐ”์— ์˜ํ•˜๋ฉด ๊ณจ์กฐ์ง์˜ ๊ฐœ์กฐ ๊ณผ์ •์—์„œ ์น˜์ฃผ์ธ๋Œ€์„ธํฌ์™€ ๊ณจ์•„์„ธํฌ๋Š” collagen ํ•ฉ์„ฑ๊ณผ alkaline phosphatase (ALP)ํ™œ์„ฑํ™”์— ์˜ํ•œ ๊ณจ์ƒ์„ฑ ๊ธฐ๋Šฅ๊ณผ ํŒŒ๊ณจ์„ธํฌ ๋ถ„ํ™”์™€ ํ™œ์„ฑ๋„์— ๊ด€์—ฌํ•˜๋Š” osteoprotegerin (OPG)๊ณผ receptor activator of nuclear factor KB ligand (RANKL)๋ฅผ ์ƒ์„ฑํ•˜์—ฌ ๊ณจํก์ˆ˜ ๊ธฐ๋Šฅ์„ ์กฐ์ ˆํ•˜๋Š” ๊ฒƒ์œผ๋กœ ๋ฐํ˜€์กŒ๋‹ค. ๊ต์ •๋ ฅ์— ์˜ํ•ด ์น˜์•„๊ฐ€ ์ด๋™ํ•  ๋•Œ ๊ธฐ๊ณ„์  ์ž๊ทน์— ์žˆ์–ด์„œ ์••๋ฐ•๋ถ€์œ„์™€ ์ธ์žฅ๋ถ€์œ„์˜ ๋ฌผ๋ฆฌ์  ์ฐจ์ด๊ฐ€ ์žˆ๊ฒŒ ๋œ๋‹ค. ์น˜์•„์ด๋™์‹œ ์น˜์ฃผ์ธ๋Œ€์™€ ์น˜์•„์˜ ์ง์ ‘์ ์ธ ์ ‘์ด‰์— ์˜ํ•ด ๋ˆŒ๋ฆฌ๋Š” ์••๋ฐ• ๋ถ€์œ„์—์„œ ๊ณจ์˜ ํก์ˆ˜๊ฐ€ ๋ฐœ์ƒํ•˜๊ณ  ์น˜์กฐ๊ณจ๊ณผ ์น˜์•„์‚ฌ์ด์˜ ๊ฑฐ๋ฆฌ๊ฐ€ ๋ฉ€์–ด์ง์œผ๋กœ ์ƒ๊ธฐ๋Š” ์ธ์žฅ ๋ถ€์œ„์—์„œ ๊ณจ์˜ ์ƒ์„ฑ์ด ์ฃผ๋กœ ์ผ์–ด๋‚˜๊ฒŒ ๋œ๋‹ค. ์ด๊ฒƒ์€ ๋ฌผ๋ฆฌ์  ์ž๊ทน์˜ ์ฃผ๊ธฐ์™€ ์ •๋„์˜ ์ฐจ์ด๊ฐ€ ํก์ˆ˜์™€ ์ƒ์„ฑ์˜ ๊ณจ๋Œ€์‚ฌ๋ฅผ ์กฐ์ ˆํ•˜์—ฌ ์••๋ฐ•๊ณผ ์ธ์žฅ์˜ ๋ฌผ๋ฆฌ์ ์ธ ์ž๊ทน์˜ ์ฐจ์ด์— ์˜ํ•ด ์—ฐ์†์ ์ธ ์ƒํ™”ํ•™์  ๋ฐ˜์‘ ์ฒด๊ณ„๊ฐ€ ๊ฒฐ์ •๋˜๊ธฐ ๋•Œ๋ฌธ์ด๋‹ค.์ด๋Ÿฌํ•œ ๊ธฐ๊ณ„์  ์ž๊ทน์˜ ์˜ํ–ฅ์— ๋Œ€ํ•œ ์„ธํฌ์˜ ๋ฐ˜์‘๊ธฐ์ „์„ ๋ฐํžˆ๊ธฐ ์œ„ํ•ด์„œ ์œ ์—ฐํ•œ ์„ฑ์žฅํ‘œ๋ฉด์„ ๊ฐ€์ง„ ๋ฐฐ์–‘ ์šฉ๊ธฐ ํ‘œ๋ฉด์„ ์ผ์‹œ์— ๋Š˜๋ฆฌ๊ณ  ์ธ์žฅ๋œ ํ˜•ํƒœ๋ฅผ ์œ ์ง€์‹œํ‚ค๋Š” ๋ฐฉ๋ฒ•๊ณผ ์ด์™„๊ณผ ์‹ ์žฅ์„ ๋ฐ˜๋ณตํ•˜๊ฒŒ ํ•˜์—ฌ ์ฃผ๊ธฐ์ ์ธ ์ธ์žฅ๋ ฅ์„ ๊ฐ€ํ•˜๋Š” ๋ฐฉ๋ฒ•์ด ์ฃผ๋กœ ์ด์šฉ๋˜์—ˆ๋‹ค. ๋Œ€๋ถ€๋ถ„์˜ ์—ฐ๊ตฌ์—์„œ ์ธ์žฅ๋ ฅ์˜ ๋ฐ˜์‘์œผ๋กœ ๊ณจํ˜•์„ฑ ์ธ์ž์ธ ALP์˜ ํ™œ์„ฑํ™”์™€ ๊ณจ ํก์ˆ˜์ธ์ž์ธ interleukin-1ฮฒ (IL-1ฮฒ)์™€ prostaglandin E2 (PGE2)์˜ ์ƒ์„ฑ์ด ์ฆ๊ฐ€ํ•˜์˜€๋‹ค. ์ด๋Ÿฌํ•œ ๊ฒฐ๊ณผ๋“ค์€ ๊ธฐ๊ณ„์  ์ž๊ทน์— ๋Œ€ํ•œ ์„ธํฌ์˜ ๋ฐ˜์‘์€ ๋‚˜ํƒ€๋‚ผ ์ˆ˜ ์žˆ์ง€๋งŒ ์น˜์•„์ด๋™์‹œ ์น˜์กฐ๊ณจ์˜ ์ƒ์„ฑ์ด ์ฃผ๋กœ ์ผ์–ด๋‚˜๋Š” ์ธ์žฅ๋ถ€์œ„์˜ ์ธ์žฅ๋ ฅ ํšจ๊ณผ๋ฅผ ์ถฉ๋ถ„ํžˆ ์„ค๋ช…ํ•  ์ˆ˜ ์—†์—ˆ๋‹ค. ์ธ์žฅ๋ถ€์œ„์˜ ๊ณจ์˜ ์ƒ์„ฑ์€ ๊ณจํ˜•์„ฑ ์ธ์ž๊ฐ€ ์ฆ๊ฐ€ํ•˜๊ฑฐ๋‚˜ ๊ณจํก์ˆ˜ ์ธ์ž๊ฐ€ ์–ต์ œ๋˜์–ด์•ผ ํ•˜๊ธฐ ๋•Œ๋ฌธ์ด๋‹ค. ์ด๋ ‡๊ฒŒ ์ƒ์ฒด๋ฐ˜์‘๊ณผ ์ผ์น˜ํ•˜์ง€ ์•Š๊ธฐ ๋•Œ๋ฌธ์— ์น˜์•„์ด๋™์‹œ ์น˜์ฃผ์ธ๋Œ€ ์„ธํฌ๊ฐ€ ๋ฐ›๋Š” ์œ ์‚ฌํ•œ ์กฐ๊ฑด์„ ์žฌํ˜„ํ•˜๋Š” ์‹คํ—˜๋ฐฉ๋ฒ•์˜ ์‹œ๋„๊ฐ€ ํ•„์š”ํ•˜๊ฒŒ ๋˜์—ˆ๋‹ค. ์ด ์—ฐ๊ตฌ๋Š” ์น˜์ฃผ์ธ๋Œ€ ์„ธํฌ์— ์ง€์†์ ์ด๊ณ  ์ ์ง„์  ์ธ์žฅ๋ ฅ์„ ๊ฐ€ํ•˜์—ฌ ์น˜์•„ ์ด๋™์‹œ ํ˜•์„ฑ๋˜๋Š” ์ธ์žฅ๋ถ€์œ„์˜ ๊ธฐ๊ณ„์  ์ž๊ทน์— ๋Œ€ํ•œ ์ƒํ™”ํ•™์  ์ „๋‹ฌ๊ณผ ์น˜์กฐ๊ณจ ํก์ˆ˜์™€ ์ƒ์„ฑ ์กฐ์ ˆ ๊ธฐ์ „์„ ์ดํ•ดํ•˜๊ณ ์ž ํ•˜์˜€๋‹ค. ๊ทธ๋ž˜์„œ ์น˜์ฃผ์ธ๋Œ€ ์„ธํฌ๊ฐ€ ๋ฐฐ์–‘๋œ ์œ ์—ฐํ•œ ์„ฑ์žฅํ‘œ๋ฉด์„ ๊ฐ€์ง„ ๋ฐฐ์ง€์— ์ง€์†์ ์ด๊ณ  ์ ์ง„์ ์ธ ์ธ์žฅ๋ ฅ์„ ๊ฐ€ํ•˜๊ณ  ๊ณจํก์ˆ˜ ์ธ์ž์ธ PGE2๊ณผ ๊ณจํ˜•์„ฑ ์ธ์ž์ธ ALP์˜ ์ƒ์„ฑ๋Ÿ‰์„ 1, 3, 6, 12์‹œ๊ฐ„ ํ›„์— ์ธก์ •ํ•˜์—ฌ ์ •๋Ÿ‰๋น„๊ต ํ•˜์˜€๋‹ค. ๊ทธ๋ฆฌ๊ณ  ํŒŒ๊ณจ์„ธํฌ ๋ถ„ํ™”๊ธฐ์ „์„ ์กฐ์ ˆํ•˜๋Š” OPG, RANKL์˜ ์ธ์ž๋“ค๊ณผ collagen์„ ๋ถ„ํ•ด ์กฐ์ ˆํ•˜๊ณ  ํŒŒ๊ณจ์„ธํฌ๊ฐ€ ๊ณจํ‘œ๋ฉด์— ๋ถ€์ฐฉ๋˜๋„๋ก osteoid ์ธต์„ ์ œ๊ฑฐํ•˜๋Š”๋ฐ ๊ด€์—ฌํ•˜๋Š” Matrix metalloproteinase (MMP)-1, -8, -9, -13, Tissue inhibitor of matrix metalloproteinase (TIMP)-1์˜ ์ธ์ž๋“ค์„ ์—ญ์ „์‚ฌ ์ค‘ํ•ฉํšจ์†Œ ์—ฐ์‡„๋ฐ˜์‘ ๊ฒ€์‚ฌํ•˜์—ฌ m-RNA ๋ฐœํ˜„์„ ๋น„๊ตํ•˜์—ฌ ๋‹ค์Œ๊ณผ ๊ฐ™์€ ๊ฒฐ๊ณผ๋ฅผ ์–ป์—ˆ๋‹ค. 1. ์น˜์ฃผ์ธ๋Œ€ ์„ธํฌ์— ์ธ์žฅ๋ ฅ์„ ๊ฐ€ํ•œ ๊ฒฝ์šฐ 1์‹œ๊ฐ„ ํ›„ ๋Œ€์กฐ๊ตฐ๋ณด๋‹ค PGE2์˜ ๋†๋„๊ฐ€ ์ ์—ˆ๊ณ  ( p < 0.05 ) ALP์˜ ๋†๋„ ๋ณ€ํ™”๋Š” ์—†์—ˆ๋‹ค.2. ์น˜์ฃผ์ธ๋Œ€ ์„ธํฌ์— ์ธ์žฅ๋ ฅ์„ ๊ฐ€ํ•œ ๊ฒฝ์šฐ OPG์˜ mRNA ๋ฐœํ˜„์ด ์ฆ๊ฐ€ํ•˜์˜€์œผ๋‚˜, RANKL์˜ mRNA ๋ฐœํ˜„์€ ๊ฐ์†Œํ•˜์˜€๋‹ค.3. ์น˜์ฃผ์ธ๋Œ€ ์„ธํฌ์— ์ธ์žฅ๋ ฅ์„ ๊ฐ€ํ•œ ๊ฒฝ์šฐ 12์‹œ๊ฐ„ ํ›„ TIMP-1๊ณผ MMP-1,-8,-9,-13์˜ mRNA ๋ฐœํ˜„์ด ๋Œ€์กฐ๊ตฐ๊ณผ ์ฐจ์ด๊ฐ€ ์—†์—ˆ๋‹ค. ์ด ์—ฐ๊ตฌ์—์„œ ์‚ฌ๋žŒ์˜ ์น˜์ฃผ์ธ๋Œ€ ์„ธํฌ๋Š” ์ ์ง„์ ์ด๊ณ  ์ง€์†์ ์ธ ์ธ์žฅ๋ ฅ์— ๋Œ€ํ•œ ๋ฐ˜์‘์œผ๋กœ PGE2์˜ ์ƒ์„ฑ๊ณผ RANKL์˜ mRNA ๋ฐœํ˜„์€ ๊ฐ์†Œํ•˜๊ณ  OPG์˜ mRNA ๋ฐœํ˜„์€ ์ฆ๊ฐ€ํ•˜์˜€๋‹ค. ๊ฒฐ๋ก ์ ์œผ๋กœ ๊ต์ •๋ ฅ์— ์˜ํ•œ ์ดˆ๊ธฐ ์น˜์•„์ด๋™์‹œ ์ธ์žฅ๋ถ€์œ„์— ๊ฐ€ํ•ด์ง€๋Š” ๊ธฐ๊ณ„์  ์ž๊ทน์— ์˜ํ•ด ์น˜์ฃผ์ธ๋Œ€์กฐ์ง์€ ๊ณจํ˜•์„ฑ์„ ์œ ๋„ํ•˜๊ธฐ ๋ณด๋‹ค๋Š” ๊ณจํก์ˆ˜๋ฅผ ์–ต์ œํ•จ์œผ๋กœ์จ ์น˜์กฐ๊ณจ ๊ฐœ์กฐ์— ๊ธฐ์—ฌํ•˜๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค. [์˜๋ฌธ] Mechanical force induces protein synthesis alteration through genetic control. The altered proteins in turn induces a chain reaction in order to maintain tissue function and homeostasis. Tooth movement is a result of mutual physiologic responses between the periodontal ligament and alveolar bone stimulated by mechanical strain. Orthodontic force induces the PDL to transform mechanical stimuli into a biochemical messenger system. This leads to tooth movement by alveolar bone apposition and resorption. The PDL cell and osteoblast are known to have an influence on bone formation by controlling collagen synthesis and alkaline phosphatase activation. Moreover, recent studies have shown that the PDL cell and osteoblast release osteoprotgerin (OPG) and receptor activator of nuclear factor KB ligand (RANKL) to control the level of osteoclast differentiation and activation which in turn influences bone resorption. There is a difference in the type of physical force between pressure and tensional area during tooth movement. In the pressure area bone resorption occurs by direct contact of the tooth and PDL whereas in the tensional area widening of the PDL space leads to bone apposition. Bone apposition and resorption is influenced by the frequency and amount of physical force.Two methods have been used to illuminate the the mechanism of cellular response to mechanical stimuli. One method applies tensional force at a single moment on a petripeherm dish with a flexible membrane. The other method creates cyclic tensional force by repeating contractional and tensional force. In most of these studies the result of tensional force application was ALP activation which stimulates bone formation and enhancement of IL-1ฮฒ and PGE2 which stimulate bone resorption. But in the tensional area bony apposition is dominantly observed rather than bone resorption. Thus, former studies fail to explain the bone apposition phenomena as a result of tensional force since bone apposition can be stimulated by either enhancement of bone formation or suppression of bone resorption. Therefore a new method must be designed. The first thing to consider is to apply different kinds of mechanical force for the tensional and pressure area. In the pressure area cells become pressed because of narrowing of the PDL space whereas in tensional area cells are elongated because of widening of the PDL space. Secondly, the force level should be as high as above the threshold level but should not be as high to be harmful to the cell. The last thing to consider is that the force should be continuously applied so that many cells can be influenced. In this study, progressively increased, continuous tensional force was applied to PDL cells. The objective was to find out which kind of biochemical reactions occur after tensional force application and to illuminate the alveolar bone resorption and apposition mechanism. Continuous and progressively increased tensile force was applied to PDL cells cultured on a petriperm dish with a flexible membrane. The amount of PGE2 and ALP synthesis were measured after 1,3,6 and 12 hours of force application. Secondly, RT-PCR analysis was carried out for OPG and RANKL which control osteoclast differentiation and MMP-1,8,9,13 and TIMP-1 which regulate the resolution of collagen and resorption of osteoid layer. The obtained results were as follows;1. After one hour of tensile force application to PDL cells the amount of PGE2 was smaller compared to control ( p< 0.05 ) and there was no change in the amount of ALP.2. The amount of OPG mRNA expression increased for the PDL cells after 12 hours of tensile force application whereas the amount of OPGL mRNA expression decreased. 3. There was no difference considering the amount of TIMP-1, MMP-1, MMP-8, MMP-9, MMP-13 mRNA expression compared to control after 12 hours of tensile force application to PDL cells.According to the results of this study, we concluded that progressively increased, continuous force application to human PDL cells reduces PGE2 synthesis, increases OPG mRNA expression and reduces RANKL mRNA expression. Therefore the initial response to tensional force in the PDL is characterized by suppression of osteoclastogenesis rather than bone formation mechanism.ope

    2์ฐจ์› ๊ณต๋™์„ ์ง€๋‚˜๋Š” ๋น„์ •์ƒ ์••์ถ•์„ฑ ์œ ๋™์˜ ์ˆ˜์น˜ํ•ด์„

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :๊ธฐ๊ณ„๊ณตํ•™๊ณผ,1998.Maste

    Ti:Sapphire ๋ ˆ์ด์ € ๊ณต์ง„๊ธฐ์˜ ๊ตฌ์„ฑ๊ณผ Kerr ๋ Œ์ฆˆ ๋ชจ๋“œ๋กํ‚น์— ์˜ํ•œ ๊ทน์ดˆ๋‹จ ํŽ„์Šค ์ƒ์„ฑ

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :๋ฌผ๋ฆฌํ•™๊ณผ,1997.Maste

    (A) posteroanterior cephalometric study on craniofacial proportions of Koreans with normal occlusion

    No full text
    ์น˜์˜ํ•™๊ณผ/์„์‚ฌ[ํ•œ๊ธ€] ๋‘๊ฐœ ์•…์•ˆ๋ฉด ๊ธฐํ˜• ํ™˜์ž์˜ ์ข…ํ•ฉ์ ์ธ ์น˜๋ฃŒ๋ฅผ ์œ„ํ•ด์„œ๋Š” ์ž…์ฒด์ ์ธ ํ‰๊ฐ€์™€ ์ง„๋‹จ์ด ์ค‘์š”ํ•˜๋‹ค. ๊ทธ๋Ÿฌ๋‚˜ ํ”ํžˆ ์ „ํ›„๋ฐฉ์ ์ธ ๊ณจ๊ฒฉ ํ‰๊ฐ€์—๋Š” ๋งŽ์€ ๋ถ„์„ ๋ฐฉ๋ฒ•์„ ์‹œํ–‰ํ•˜๊ณ ์žˆ์œผ๋‚˜, ์•ˆ๋ชจ ๋น„๋Œ€์นญ๊ณผ ์ƒํ•˜์•…๊ณจ ํšก์ ์ธ ๋ถ€์กฐํ™”์˜ ์ง„๋‹จ์„ ์œ„ํ•ด ํ•„์š”ํ•œ ํšก์  ํ‰๊ฐ€๋ฐฉ๋ฒ•์€ ์ถฉ๋ถ„ํ•˜์ง€ ๋ชปํ•œ ์‹ค์ •์ด๋‹ค. ํšก์ ์ธ ๋ถ€์กฐํ™”์˜ ์ ์ ˆํ•œ ์ง„๋‹จ๊ณผ ์น˜๋ฃŒ๋Š” ์•ˆ์ •๋œ ๊ธฐ๋Šฅ๊ตํ•ฉ์˜ ํ˜•์„ฑ์— ์žˆ์–ด์„œ ์ „ํ›„๋ฐฉ ๋˜๋Š” ์ˆ˜์ง์ ์ธ ๋ถ€์กฐํ™”๋ณด๋‹ค ์ค‘์š”ํ•œ ์—ญํ• ์„ ํ•˜๋ฉฐ, ์žฅ๊ธฐ๊ฐ„์˜ ์•ˆ์ •์„ฑ์—๋„ ์˜ํ–ฅ์„ ๋ฏธ์นœ๋‹ค. ๊ทธ๋ฆฌ๊ณ  ์ƒํ•˜์•…์˜ ํšก์ ์ธ ๋ถ€์กฐํ™”์— ๋”ฐ๋ฅธ ์—ฐ์กฐ์ง์˜ ๋ณ€ํ™”๊ฐ€ ์ œํ•œ๋˜์–ด์žˆ๊ธฐ ๋•Œ๋ฌธ์— ์‚ฌ์ง„์„ ํ†ตํ•œ ์ž„์ƒ์  ๋ฐฉ๋ฒ•์œผ๋กœ๋Š” ๊ฐ„๊ณผ๋˜๊ธฐ ์‰ฌ์šฐ๋ฉฐ ๋”์šฑ์ด ํŠน์ง•์ ์ธ ์•ˆ๋ชจ ์†Œ๊ฒฌ์„ ๋ณด์ด๋Š” ์ „ํ›„๋ฐฉ ๋˜๋Š” ์ˆ˜์ง์ ์ธ ๋ถ€์กฐํ™”์™€ ๋™๋ฐ˜๋œ ๊ฒฝ์šฐ์—๋Š” ๊ฐ๋ณ„๋˜๊ธฐ ์–ด๋ ต๋‹ค. ๊ทธ๋กœ ์ธํ•ด ์ •ํ™•ํ•œ ์ง„๋‹จ๊ณผ ์น˜๋ฃŒ๋ฅผ ์œ„ํ•ด์„œ๋Š” ์ •์ƒ ์•ˆ๋ชจ์— ๊ด€ํ•œ ์ •๋ชจ ๋‘๋ถ€๋ฐฉ์‚ฌ์„  ๊ณ„์ธกํ•™์  ์•ˆ๋ชจ ๋น„์œจ์˜ ํ‰๊ฐ€๊ฐ€ ํ•„์š”ํ•˜๊ฒŒ ๋˜์—ˆ๋‹ค. ๋ณธ ์—ฐ๊ตฌ๋Š” 1996ํ•™๋…„๋„ ์—ฐ์„ธ๋Œ€ํ•™๊ต ์‹ ์ž…์ƒ์ค‘์—์„œ ํ˜‘์กฐ ๊ฐ€๋Šฅํ•œ ์ •์ƒ ์•ˆ๋ชจ์™€ ๊ฑฐ์˜ ์ •์ƒ ๊ตํ•ฉ์„ ๊ฐ–์€ ๋‚จ๋…€ 76๋ช…์„ ์„ ์ •ํ•˜์—ฌ ์•ˆ๋ชจ ๋น„๋Œ€์นญ๊ณผ ํšก์ ์ธ ๋ถ€์กฐํ™”๊ฐ€ ์žˆ๋Š” ์•…์•ˆ๋ฉด ๊ธฐํ˜• ํ™˜์ž์˜ ์ง„๋‹จ๊ณผ ์น˜๋ฃŒ๊ณ„ํš์— ๋„์›€์„ ์ฃผ๋Š” ์ž๋ฃŒ๋ฅผ ์–ป๊ณ ์ž ์ •๋ชจ ๋‘๋ถ€ ๋ฐฉ์‚ฌ์„  ๊ณ„์ธก์‚ฌ์ง„์„ ์ด์šฉํ•˜์—ฌ ์ˆ˜ํ‰ ๋ฐ ์ˆ˜์ง ๊ณ„์ธกํ•ญ๋ชฉ๊ณผ ๊ทธ ๋น„์œจ์„ ํ†ต๊ณ„์ฒ˜๋ฆฌํ•˜์—ฌ ๋‹ค์Œ๊ณผ ๊ฐ™์€ ๊ฒฐ๊ณผ๋ฅผ ์–ป์—ˆ๋‹ค. 1. ์ •๋ชจ์˜ ์ˆ˜ํ‰ ๋ฐ ์ˆ˜์ง์ ์ธ ๊ณ„์ธกํ•ญ๋ชฉ๊ณผ ๊ทธ ๋น„์œจ์˜ ํ‰๊ท ๊ฐ’๊ณผ ํ‘œ์ค€ํŽธ์ฐจ๋ฅผ ๊ตฌํ•˜์˜€๋‹ค. 2. ์ •๋ชจ์˜ ํญ๊ฒฝ์— ๋Œ€ํ•œ ๊ณ ๊ฒฝ์˜ ๋น„์œจ์€ 0.837(๋‚จ์ž: 0.836, ์—ฌ์ž: 0.841)์ด์—ˆ๋‹ค. 3. ์ƒ์•…๊ณจ๊ณผ ํ•˜์•…๊ณจ๊ฐ„์˜ ํญ๊ฒฝ๋น„์œจ์€ 0.747(๋‚จ์ž: 0.745, ์—ฌ์ž: 0.752)์ด๋ฉฐ, ๋†’์€ ์—ฐ๊ด€์„ฑ์„ ๋‚˜ํƒ€๋‚ด์—ˆ๋‹ค. 4. ๋‘๊ฐœ ์•ˆ๋ฉด๋ถ€ ํญ๊ฒฝ๋“ค๊ฐ„์—๋Š” ์„œ๋กœ ์—ฐ๊ด€์„ฑ์ด ๋‚˜ํƒ€๋‚ฌ๋‹ค. (๋‘๊ฐœํญ๊ฒฝ, ๊ด€๊ณจ์ „๋‘๋ด‰ํ•ฉํญ๊ฒฝ, ์•ˆ๋ฉดํญ๊ฒฝ, ์ƒ์•…ํญ๊ฒฝ, ํ•˜์•…ํญ๊ฒฝ, ์ƒ์•…๊ณผ ํ•˜์•…๊ตฌ์น˜๋ถ€ํญ๊ฒฝ) 5. ์ •๋ชจ์˜ ํญ๊ฒฝ์ด ์ฆ๊ฐ€ํ• ์ˆ˜๋ก ์•ˆ๋ชจ๊ณ ๊ฒฝ๊ณผ ๋‹ค๋ฅธ ๊ธธ์ด ๊ณ„์ธก์น˜๋„ ์—ฐ๊ด€๋˜์–ด ์ฆ๊ฐ€ํ•˜์˜€์ง€๋งŒ ๊ฐ๋„ ๊ณ„์ธก๊ฐ’ (Bjork์˜ ํ•ฉ, ํ•˜์•…ํ‰๋ฉด๊ฐ)์˜ ๊ฐ์†Œ์™€, ํ›„์ „ ์•ˆ๋ฉด๊ณ ๊ฒฝ ๋น„์œจ ์ฆ๊ฐ€๋กœ ์ธํ•˜์—ฌ, Brachycephalic facial type์˜ ์•ˆ๋ชจ ๊ฒฝํ–ฅ์„ ๋ณด์˜€๋‹ค. ์ด์ƒ์˜ ๊ฒฐ๊ณผ๋Š” ์•…์•ˆ๋ฉด ๊ธฐํ˜• ํ™˜์ž์˜ ๊ต์ •์น˜๋ฃŒ ๋ฐ ์•…๊ต์ • ์ˆ˜์ˆ ์น˜๋ฃŒ์˜ ๊ณ„ํš์— ๊ธฐ์ค€์น˜๋กœ์จ ์‚ฌ์šฉ๋  ์ˆ˜ ์žˆ์„ ๊ฒƒ์ด๋‹ค. [์˜๋ฌธ] For the total treatment of skeletal malocclusions, 3-dimensional evaluation and diagnosis are essential. Although anteroposterior discrepancies can be evaluated through various methods, the satisfactory methods for evaluations of facial asymmetry and transverse discrepancies are yet to be found. The adequate diagnosis and treatment of transverse discrepancies may be more important in the maintenance of functional occlusion as well as for the stability of results obtained from orthognathic surgery than the anteroposterior or vertical discrepancies. Since the soft tissue effects from the transverse discrepancies may not be pronounced, especially when combined with anteroposterior or vertical discrepancies which have prominent characteristics, the differentiation of their effects may be difficult from visual inspection alone. Therefore it is essential that the normal facial proportions would be established from the posteroanterior cephalometry as a reference for the accurate diagnosis and treatment. The present study evaluates 76 subjects from Yonsei University freshmen with normal facial symmetry and occlusion, Posteroanterior cephalograms were taken from the subjects and the normal values and facial proportions are obtained. The results are as follows. 1. The transverse and vertical values from posteroanterior cephalometry and their ratio, with means and standard deviations are calculated. 2. The ratio of vertical values to transverse values is 0.837 (male 0.836, female 0.841). 3. The proportion of maxillary and mandibular widths is 0.747 (male 0.745, female 0.752), with statistically significant correlation. 4. Various degree of significant correlations are observed in the following craniofacial widths; (Cranial width, Bizygomaticofrontal suture width, Facial width, Maxillary width, Upper & Lower Intermolar width, Mandibular width). 5. Although the facial height as well as other line measurements increase as the facial widths increase, angle measurement (Bjork Sum, Mandibular Plane Angle, Gonial Angle), decreases and posterior to anterior facial height ratio increases, therefore indicating the tendency for a brachycephalic facial type. These results may be used as references for the treatment planning in orthognathic and orthodontic treatments for the dentofacial deformity patients.restrictio

    ์ธ๊ฐ„ ๋ฐฐ์•„์ค„๊ธฐ์„ธํฌ์˜ ํ™•๋ฆฝ๊ณผ ํŠน์„ฑ๋ถ„์„

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์˜ํ•™๊ณผ ์‚ฐ๋ถ€์ธ๊ณผํ•™์ „๊ณต,2003.Maste
    corecore